DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Fostamatinib
Fostamatinib
Tavalisse™ (Fostamatinib) (Oral) Document Number: IC-0361 Last Review Date: 02/02/2021 Date of Origin: 06/01/2018 Dates Reviewed: 06/2018, 02/2019, 02/2020, 02/2021
Blood Modifier Agents Policy #: Rx.01.208
Farmaatsia- Terminoloogia Teine, Täiendatud Trükk
New Drug Evaluation Monograph Template
Nplate® (Romiplostim)
Fostamatinib
Perioperative Medication Management - Adult/Pediatric - Inpatient/Ambulatory Clinical Practice Guideline
May 2017 Monitoring International Trends
Committee for Medicinal Products for Human Use (CHMP) Agenda for the Meeting on 14-17 October 2019 Chair: Harald Enzmann – Vice-Chair: Bruno Sepodes
Tenncare Attestation List September 1, 2021
Aralast NP™, Glassia™, Prolastin®-C
Lääkeaineiden Yleisnimet (INN-Nimet) 31.12.2019
Compatibility Mode
List Item PDCO Monthly Report of Opinions on Paediatric Investigation
Immune Thrombocytopenia
Tavlesse, INN-Fostamatinib
Pipeline Report
TAVLESSE, INN-Fostamatinib
Top View
Supplementary Material
June 2018 Monitoring International Trends
Doptelet Mulpleta Promacta and Tavalisse
Carecontinuum™ 1199 SEIU Drug List
Scientific Programme Sunday, 12. July 2020 Plenary Session State-Of-The-Art on Hemophilia and Rare Bleeding Disorders State-Of-T
2021 Investor and Analyst Day
New Drug Evaluation Monograph Template
Sept-Oct 2018 Monitoring International Trends (Pdf)
New Small Molecule Drugs for Thrombocytopenia: Chemical, Pharmacological, and Therapeutic Use Considerations
October 2017 a View Into Upcoming Specialty and Traditional Drugs TABLE of CONTENTS
Scientific Programme Tuesday, 17. July 2018 Registration
Final Belgian List
Avatrombopag (Doptelet®), Eltrombopag (Promacta®), Lusutrombopag (Mulpleta®), Fostamatinib (Tavalisse™) EOCCO POLICY
In-Silico Analysis of Potential Interaction of Drugs and the SARS-Cov-2 Spike Protein
AHFS Pharmacologic-Therapeutic Classification System
Optumrx Brand Pipeline Forecast
Fostamatinib Disodium Hexahydrate: a Novel Treatment for Adult
Klasifikacija ATC 2021
January 2018 a View Into Upcoming Specialty and Traditional Drugs TABLE of CONTENTS
Meds Entry Watch New Medicines Approved in 2018
Specialty Pharmacy Drug List Specialty Medications List
List of Medicinal Products Under Additional Monitoring
Tenofovir Alafenamide
Primary Immune Thrombocytopenia: Novel Insights Into Pathophysiology and Disease Management
Cellular Host Factors for SARS-Cov-2 Infection
5.01.566 Pharmacotherapy of Thrombocytopenia
TAVALISSE™ (Fostamatinib Disodium Hexahydrate) Tablets, for Oral Use Interrupt, Reduce Or Discontinue TAVALISSE